SBSB
MRK icon

Sullivan, Bruyette, Speros & Blaney’s Merck MRK Stock Holding History

Sullivan, Bruyette, Speros & Blaney’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$1.87M Buy
25,456
+943
+4% +$69.6K 0.08% 73
2020
Q4 		$1.91M Sell
24,513
-987
-4% -$75.5K 0.09% 69
2020
Q3 		$2.02M Sell
25,500
-1,746
-6% -$137K 0.11% 57
2020
Q2 		$2.01M Buy
27,246
+81
+0.3% +$6.1K 0.12% 49
2020
Q1 		$1.99M Sell
27,165
-307
-1% -$24.1K 0.14% 45
2019
Q4 		$2.38M Buy
27,472
+479
+2% +$39.3K 0.13% 42
2019
Q3 		$2.17M Sell
26,993
-29
-0.1% -$2.32K 0.13% 44
2019
Q2 		$2.16M Buy
27,022
+160
+0.6% +$12.3K 0.13% 42
2019
Q1 		$2.13M Buy
26,862
+8,630
+47% +$645K 0.13% 43
2018
Q4 		$1.33M Buy
18,232
+1,139
+7% +$80.4K 0.09% 60
2018
Q3 		$1.16M Buy
17,093
+792
+5% +$50.5K 0.1% 50
2018
Q2 		$944K Sell
16,301
-192
-1% -$10.8K 0.09% 58
2018
Q1 		$857K Sell
16,493
-2,707
-14% -$146K 0.08% 62
2017
Q4 		$1.03M Sell
19,200
-1,469
-7% -$81.4K 0.1% 58
2017
Q3 		$1.26M Sell
20,669
-490
-2% -$29.7K 0.12% 46
2017
Q2 		$1.29M Sell
21,159
-384
-2% -$23.4K 0.13% 40
2017
Q1 		$1.31M Sell
21,543
-656
-3% -$39.8K 0.13% 37
2016
Q4 		$1.25M Sell
22,199
-101
-0.5% -$5.91K 0.13% 39
2016
Q3 		$1.33M Buy
22,300
+1,093
+5% +$63.9K 0.13% 35
2016
Q2 		$1.17M Buy
+21,207
New +$1.13M 0.12% 40

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Sullivan, Bruyette, Speros & Blaney's MRK Position: Q1 2021 in Review

Sullivan, Bruyette, Speros & Blaney increased its Merck (MRK) stake by 3.8% in Q1 2021, buying an estimated $69.6K and bringing the position to 25,456 shares worth $1.87M. The position accounts for 0.08% of the portfolio, ranked #73.

Sullivan, Bruyette, Speros & Blaney first reported a position in MRK in Q2 2016 and has held it in 20 quarters since. The position peaked at $2.38M in Q4 2019. 2,687 funds tracked by Wall St. Rank hold MRK as of Q1 2021.

  • Sullivan, Bruyette, Speros & Blaney held 25,456 shares of Merck worth $1.87M as of Q1 2021.
  • Sullivan, Bruyette, Speros & Blaney bought 943 Merck shares in Q1 2021, an estimated $69.6K.
  • Merck made up 0.08% of Sullivan, Bruyette, Speros & Blaney's portfolio in Q1 2021, its #73 holding.
  • Sullivan, Bruyette, Speros & Blaney first reported a position in Merck in Q2 2016 and has held it in 20 quarters since.
  • Sullivan, Bruyette, Speros & Blaney's Merck position peaked at $2.38M in Q4 2019.
  • 2,687 funds tracked by Wall St. Rank held Merck as of Q1 2021.

Based on Sullivan, Bruyette, Speros & Blaney's 13F filing for Q1 2021, filed 10 May 2021.